| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
ARGX
Argenx Se
|
Jun 24, 2026 | BUY |
Strong Buy
-15.5% avg upside
46 analysts
|
$1016.00
14.34% Upside
|
+4.2% |
|
OCUL
Ocular Therapeutix
|
Jun 22, 2026 | BUY |
Strong Buy
+151.2% avg upside
21 analysts
|
$27.00
176.67% Upside
|
+0.0% |
|
TSHA
Taysha Gene Therapies
|
Jun 22, 2026 | BUY |
Strong Buy
+111.5% avg upside
21 analysts
|
$10.00
60.97% Upside
|
· |
|
IMMX
Immix Biopharma
|
Jun 18, 2026 | BUY |
Strong Buy
+83.3% avg upside
8 analysts
|
$27.00
177.71% Upside
|
· |
|
ASND
Ascendis Pharma
|
Jun 16, 2026 | BUY |
Strong Buy
+4.9% avg upside
24 analysts
|
$288.00
10.14% Upside
|
-0.0% |
|
RYTM
Rhythm Pharmaceuticals
|
Jun 15, 2026 | BUY |
Strong Buy
+12.0% avg upside
19 analysts
|
$149.00
37.63% Upside
|
+6.8% |
|
BLTE
Belite Bio, Inc. ADR
|
Jun 15, 2026 | BUY |
Strong Buy
+21.8% avg upside
10 analysts
|
$200.00
33.57% Upside
|
+1.1% |
|
INCY
Incyte
|
Jun 15, 2026 | BUY |
Buy
-7.1% avg upside
47 analysts
|
$124.00
15.29% Upside
|
+6.3% |
|
APGE
Apogee Therapeutics
|
Jun 11, 2026 | BUY |
Buy
-5.7% avg upside
19 analysts
|
$131.00
1.36% Downside
|
+48.3% |
|
KYMR
Kymera Therapeutics
|
Jun 08, 2026 | BUY |
Strong Buy
-13.8% avg upside
36 analysts
|
$110.00
5.63% Downside
|
+34.5% |
|
FULC
Fulcrum Therapeutics
|
Jun 02, 2026 | SELL |
Hold
+139.0% avg upside
14 analysts
|
$3.00
16.96% Downside
|
· |
|
BCAX
Bicara Therapeutics Inc.
|
Jun 02, 2026 | BUY |
Strong Buy
+18.5% avg upside
14 analysts
|
— | +27.3% |
|
GILD
Gilead Sciences
|
Jun 02, 2026 | BUY |
Strong Buy
-5.1% avg upside
66 analysts
|
$162.00
30.75% Upside
|
-2.4% |
|
BNTX
BioNTech SE
|
Jun 01, 2026 | BUY |
Strong Buy
+51.8% avg upside
26 analysts
|
$125.00
38.97% Upside
|
-0.9% |
|
DNLI
Denali Therapeutics
|
May 22, 2026 | BUY |
Strong Buy
+50.7% avg upside
24 analysts
|
— | +32.9% |
|
ANRO
Alto Neuroscience, Inc.
|
May 21, 2026 | BUY |
Strong Buy
+20.0% avg upside
13 analysts
|
$33.00
30.51% Upside
|
+15.7% |
|
FATE
Fate Therapeutics
|
May 21, 2026 | HOLD |
Buy
+535.5% avg upside
31 analysts
|
$2.20
17.60% Upside
|
-5.7% |
|
STRO
Sutro Biopharma
|
May 21, 2026 | SELL |
Strong Buy
+30.0% avg upside
20 analysts
|
— | +5.9% |
|
PEPG
PepGen Inc.
|
May 21, 2026 | SELL |
Strong Buy
+517.0% avg upside
9 analysts
|
$3.00
75.53% Upside
|
· |
|
REGN
Regeneron
|
May 17, 2026 | BUY |
Strong Buy
+24.5% avg upside
57 analysts
|
$860.00
38.60% Upside
|
-2.6% |
|
AARD
Aardvark Therapeutics, Inc.
|
May 15, 2026 | SELL |
Buy
+279.1% avg upside
12 analysts
|
$4.00
20.97% Downside
|
-0.0% |
|
PHVS
Pharvaris
|
May 14, 2026 | HOLD |
Strong Buy
+35.2% avg upside
14 analysts
|
$33.00
0.93% Downside
|
+8.8% |
|
PTCT
PTC Therapeutics
|
May 14, 2026 | BUY |
Strong Buy
-8.2% avg upside
29 analysts
|
— | +8.0% |
|
SRRK
Scholar Rock Holding
|
May 08, 2026 | BUY |
Strong Buy
+6.7% avg upside
23 analysts
|
$58.00
7.90% Upside
|
+5.9% |
|
ANNX
Annexon Biosciences
|
May 08, 2026 | BUY |
Strong Buy
+166.3% avg upside
13 analysts
|
$8.00
55.42% Upside
|
-13.9% |
|
PRTA
Prothena
|
May 08, 2026 | SELL |
Buy
+151.3% avg upside
14 analysts
|
$8.00
13.72% Downside
|
+20.9% |
|
ACAD
ACADIA Pharmaceuticals
|
May 07, 2026 | BUY |
Strong Buy
+51.9% avg upside
42 analysts
|
— | +14.4% |
|
AMGN
Amgen
|
May 01, 2026 | SELL |
Buy
-15.4% avg upside
57 analysts
|
$307.00
13.05% Downside
|
-6.0% |
|
BCRX
BioCryst
|
Apr 16, 2026 | BUY |
Strong Buy
+83.8% avg upside
24 analysts
|
— | -11.5% |
|
RARE
Ultragenyx Pharmaceutical
|
Apr 16, 2026 | BUY |
Strong Buy
+126.2% avg upside
36 analysts
|
— | -5.8% |
|
ALNY
Alnylam Pharma
|
Apr 15, 2026 | BUY |
Strong Buy
+17.4% avg upside
51 analysts
|
— | -14.1% |
|
NBIX
Neurocrine
|
Apr 15, 2026 | BUY |
Strong Buy
+4.0% avg upside
37 analysts
|
— | +20.4% |
|
VRTX
Vertex Pharmaceuticals
|
Apr 15, 2026 | BUY |
Strong Buy
-8.4% avg upside
61 analysts
|
$598.00
24.51% Upside
|
+5.7% |
|
ARVN
Arvinas Holding Company
|
Mar 18, 2026 | HOLD |
Strong Buy
+248.2% avg upside
27 analysts
|
$14.00
74.38% Upside
|
-26.3% |
|
SRPT
Sarepta Therapeutics
|
Feb 25, 2026 | SELL |
Buy
+272.0% avg upside
49 analysts
|
$19.00
18.70% Upside
|
+9.0% |
|
GB:0QW0
arGEN X
|
Dec 18, 2025 | BUY |
Strong Buy
-21.5% avg upside
24 analysts
|
— | · |
|
NMRA
Neumora Therapeutics, Inc.
|
Apr 01, 2025 | SELL |
Buy
+422.5% avg upside
11 analysts
|
$1.00
33.71% Downside
|
-102.2% |
|
FDMT
4D Molecular Therapeutics
|
Sep 19, 2024 | BUY |
Strong Buy
+205.5% avg upside
15 analysts
|
$79.00
585.84% Upside
|
-32.2% |
|
ADCT
ADC Therapeutics
|
Oct 17, 2023 | SELL |
Strong Buy
+468.8% avg upside
12 analysts
|
$1.00
3.83% Downside
|
-432.6% |
|
GRTX
Galera Therapeutics
|
Aug 11, 2023 | SELL |
Buy
+6568.5% avg upside
7 analysts
|
$0.50
461.82% Upside
|
· |
|
PYXS
Pyxis Oncology
|
May 24, 2023 | HOLD |
Strong Buy
+213.4% avg upside
13 analysts
|
$4.00
79.39% Upside
|
-63.2% |
|
PRLD
Prelude Therapeutics
|
Mar 27, 2023 | SELL |
Buy
+163.6% avg upside
7 analysts
|
$6.00
46.36% Upside
|
+89.1% |
|
PRAX
Praxis Precision Medicines
|
Mar 06, 2023 | HOLD |
Strong Buy
+66.2% avg upside
24 analysts
|
$22.50
93.12% Downside
|
+127.5% |
|
SQZB
SQZ Biotechnologies
|
Dec 01, 2022 | SELL |
Buy
+102677.7% avg upside
7 analysts
|
$20.00
83233.26% Upside
|
+24.3% |
|
SRZN
Surrozen
|
Nov 16, 2022 | SELL |
Buy
+41.2% avg upside
7 analysts
|
$1.00
95.92% Downside
|
+51.5% |
|
TBPH
Theravance Biopharma
|
Apr 19, 2022 | SELL |
Buy
+7.1% avg upside
18 analysts
|
$9.00
48.30% Downside
|
-3.0% |
|
KALA
KALA BIO
|
Jul 21, 2021 | BUY |
Strong Buy
+7491.0% avg upside
9 analysts
|
$8.00
213.73% Upside
|
-92.5% |
|
MRNA
Moderna
|
Jan 25, 2021 | HOLD |
Hold
+14.5% avg upside
38 analysts
|
$150.00
151.00% Upside
|
+31.3% |
|
QNCX
Quince Therapeutics
|
Jun 03, 2019 | HOLD |
Hold
+2193.2% avg upside
15 analysts
|
$28.00
2768.53% Upside
|
+87.7% |
|
ALEC
Alector
|
Mar 04, 2019 | BUY |
Hold
+497.5% avg upside
14 analysts
|
$26.00
1305.31% Upside
|
-22.1% |
|
DBVT
DBV Technologies SA - American
|
Dec 20, 2018 | SELL |
Buy
+50.6% avg upside
15 analysts
|
$8.00
49.98% Downside
|
+47.7% |
|
PCRX
Pacira Pharmaceuticals
|
Oct 10, 2018 | HOLD |
Buy
+60.5% avg upside
21 analysts
|
$48.00
97.01% Upside
|
+27.2% |
|
MCRB
Seres Therapeutics
|
Aug 03, 2018 | SELL |
Buy
+142.9% avg upside
11 analysts
|
$6.00
12.39% Downside
|
+45.8% |
|
ACET
Adicet Bio
|
Feb 20, 2018 | BUY |
Strong Buy
+218.8% avg upside
14 analysts
|
$23.00
191.22% Upside
|
-92.5% |
|
SPRO
Spero Therapeutics
|
Nov 27, 2017 | HOLD |
Buy
+574.3% avg upside
12 analysts
|
$16.00
692.14% Upside
|
-16.1% |
|
RMTI
Rockwell Med
|
Nov 08, 2016 | SELL |
Buy
+1365.1% avg upside
11 analysts
|
$5.00
668.19% Upside
|
+20.4% |
|
CORT
Corcept Therapeutics
|
Jun 02, 2016 | SELL |
Buy
-48.4% avg upside
15 analysts
|
$5.00
94.11% Downside
|
-196.0% |
|
INVA
Innoviva
|
Sep 09, 2015 | SELL |
Buy
+22.3% avg upside
12 analysts
|
$13.00
44.42% Downside
|
-29.2% |
|
GLNG
Golar LNG
|
Sep 19, 2014 | BUY |
Strong Buy
-12.8% avg upside
22 analysts
|
$110.00
119.75% Upside
|
-67.9% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.